Statistics
Publications
30
Citations
3.7K
H-Index
19
Active since
2008
Ayman Samkari is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in oncology, pembrolizumab therapy, and medicine.
Publications per year
2008–2024
30
30
Mary O’Brien, Luis Paz‐Ares, Sandrine Marréaud et al. · The Lancet Oncology · 2022 · 744 citations
Medicine, Oncology, Pharmacology +16
Roy S. Herbst, Edward B. Garon, Dong‐Wan Kim et al. · Journal of Thoracic Oncology · 2021 · 312 citations · Full text
Medicine, Oncology, Pharmacotherapy +16
Roy S. Herbst, Edward B. Garon, Dong‐Wan Kim et al. · Journal of Clinical Oncology · 2020 · 281 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 30